Skip to main content

Mesoblast Ltd

MESO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001345099

No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.

Other share classesMEOBF

Superinvestors holding MESO, Q2 2026

See all superinvestors

No superinvestor reported holding MESO in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of MESO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q1 2025

    0 superinvestors holding at quarter end

    Sold out
    Oaktree Capital
  2. Q4 2024

    1 superinvestor holding at quarter end

    New
    Oaktree Capital